Modified ESHAP as Salvage Chemotherapy for Recurrent or Refractory Non-Hodgkin’s Lymphoma: Results of a Single-Center Study of 32 Patients-Reference-Cited by-同舟云学术

Modified ESHAP as Salvage Chemotherapy for Recurrent or Refractory Non-Hodgkin’s Lymphoma: Results of a Single-Center Study of 32 Patients

Published:2002 Issue:5 Volume:48 Page:252-258
ISSN:0009-3157
Container-title:Chemotherapy
language:en
Short-container-title:Chemotherapy

Author:

Öztürk Mehmet Akif,Barışta İbrahim,Altundağ M. Kadri,Türker Alev,Yalçın Şuayib,Çelik İsmail,Güllü İbrahim H.,Güler Nilüfer,Özışık Yavuz,Kars Ayşe,Kansu Emin,Baltalı Eşmen,Tekuzman Gülten

Publisher

S. Karger AG

Subject

Infectious Diseases,Pharmacology (medical),Drug Discovery,Pharmacology,Oncology,General Medicine

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer Agent Effect and Polychemotherapy Regimens for Malignant Tumor Treatment - A Review;Galician Medical Journal;2022-06-01

2. Oncological Treatment-Related Fatigue in Oncogeriatrics: A Scoping Review;Cancers;2022-05-17

3. Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Therapy in Aggressive Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome;Clinical Lymphoma Myeloma and Leukemia;2013-10

4. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours;European Journal of Cancer;2011-01

5. Gemcitabine and treatment of diffuse large B-cell lymphoma in relapsed or refractory elderly patients: A prospective randomized trial in Algeria;Journal of Cancer Research and Therapeutics;2010